Aug. 17-26
Various locations
This year’s fest has 68 shows to choose from ranging from family-friendly magic shows to recommended-for-adult-audiences burlesque. In between, there’s drama, comedy and a sequel to last year’s hit, “Schoolhouse Wrong.” Indy Fringe, now in its eighth year, is wisely structured so that all six participating theater spaces have shows running at the same time. Each of these shows runs about an hour, taking most patrons off the street during show times. But then there’s that half-hour gap between them to schmooze, compare notes, grab a frozen yogurt, and hustle to the next show.
The system makes it possible to see as many as seven shows in a day—not that I’d recommend that kind of overload. Rather, try a trio of shows in a day with some time off for lunch or dinner. Each show will set you back $10. (Full disclosure: I co-created one of the 68 shows.) Full schedule and details here.

















Three Magi
Cats out of the bag. The object of the game is to get acquired. That means the company has no idea how to grow beyond a certain point. Email is a 1990s technology. I have laughed at this company since day one. Such a small bit player. If it was anywhere but here, it wouldn't be newsworthy.
Esther, Indy has passed Chicago in the local government corruption arena. Don't downgrade us. We're No. 1 in the Midwest.
Does the buyer get to keep the recent Accu-Chek J.D. Power award? Be careful, those Swiss cannot be trusted. Last June they pimped Mayor Ballard and former Governor Daniels at a media op, announcing plans to invest "$300 million at its Indianapolis headquarters, creating up to 100 new jobs by 2017," only to turn around and close the Roche Nutley, NJ facility and eliminate 1000 jobs there later the same week. It seems that healthcare can be innovated only as long as money is to be made. Right now Roche seems to have big eyes for China: there are many Chinese in China and potential billions in Swiss francs! Since Roche is having difficulty with US insurance companies swallowing the bill for overpriced cancer drugs (with debatable efficacy) why not sell insurance to the Chinese and market the drugs to them there? There is a name for these sort of business practices however proper decorum precludes it use in this forum.
Same kind of Luddites who oppose I-69. Guessing their 501(c)(4) application probably sailed right through the IRS.